[go: up one dir, main page]

SV1997000047A - Antagonistas de receptor de benzoxazinona dopamina d4 - Google Patents

Antagonistas de receptor de benzoxazinona dopamina d4

Info

Publication number
SV1997000047A
SV1997000047A SV1997000047A SV1997000047A SV1997000047A SV 1997000047 A SV1997000047 A SV 1997000047A SV 1997000047 A SV1997000047 A SV 1997000047A SV 1997000047 A SV1997000047 A SV 1997000047A SV 1997000047 A SV1997000047 A SV 1997000047A
Authority
SV
El Salvador
Prior art keywords
dopamine
benzoxazinone
receptor antagonists
receptor
receptors
Prior art date
Application number
SV1997000047A
Other languages
English (en)
Inventor
Thomas Belliotti
Lawrence David Wise
David Juergen Wustrow
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SV1997000047A publication Critical patent/SV1997000047A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

ESTA INVENCION SE RELACIONA CON COMPUESTOS QUE SON ANTAGONISTAS DE RECEPTORES DE DOPAMINA D4, CON METODOS PARA TRATAR LA PSICOSIS Y LA ESQUIZOFRENIA, USANDO UN COMPUESTO QUE ES UN ANTAGONISTA DE RECEPTORES DE DOPAMINA D4 Y CON COMPOSICIONES FARMACOLOGICAMENTE ACEPTABLES QUE CONTIENEN UN ANTAGONISTA DE RECEPTOR DE DOPAMINA D4.
SV1997000047A 1996-05-29 1997-05-28 Antagonistas de receptor de benzoxazinona dopamina d4 SV1997000047A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1838396P 1996-05-29 1996-05-29
US4020897P 1997-03-06 1997-03-06

Publications (1)

Publication Number Publication Date
SV1997000047A true SV1997000047A (es) 1998-08-13

Family

ID=26691052

Family Applications (1)

Application Number Title Priority Date Filing Date
SV1997000047A SV1997000047A (es) 1996-05-29 1997-05-28 Antagonistas de receptor de benzoxazinona dopamina d4

Country Status (36)

Country Link
EP (1) EP0906294B1 (es)
JP (1) JP2000511534A (es)
KR (1) KR20000016151A (es)
CN (1) CN1074764C (es)
AR (1) AR008372A1 (es)
AT (1) ATE231846T1 (es)
AU (1) AU731104B2 (es)
BG (1) BG64049B1 (es)
BR (1) BR9709630A (es)
CA (1) CA2253406A1 (es)
CO (1) CO4940505A1 (es)
CZ (1) CZ384698A3 (es)
DE (1) DE69718786T2 (es)
DK (1) DK0906294T3 (es)
EA (1) EA001486B1 (es)
EE (1) EE03686B1 (es)
ES (1) ES2191180T3 (es)
GE (1) GEP20012389B (es)
HN (1) HN1997000075A (es)
HR (1) HRP970301B1 (es)
HU (1) HUP9903758A3 (es)
ID (1) ID17266A (es)
IL (1) IL126895A (es)
NO (1) NO312296B1 (es)
NZ (1) NZ332737A (es)
PA (1) PA8431101A1 (es)
PE (1) PE69398A1 (es)
PL (1) PL330195A1 (es)
PT (1) PT906294E (es)
RO (1) RO120845B1 (es)
SI (1) SI0906294T1 (es)
SK (1) SK282703B6 (es)
SV (1) SV1997000047A (es)
TW (1) TW542833B (es)
UY (1) UY24569A1 (es)
WO (1) WO1997045419A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177422B1 (en) 1996-05-29 2001-01-23 Warner-Lambert Company Benzoxazinone dopamine D4 receptor antagonists
GB9801392D0 (en) * 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds
AU4832699A (en) * 1998-06-30 2000-01-17 Neurogen Corporation 1-(benzothiazol-2-yl)-4-(1-phenylmethyl)piperazines: dopamine receptor subtype specific ligands
US6177566B1 (en) 1998-06-30 2001-01-23 Neurogen Corporation 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands
AU4720499A (en) * 1998-06-30 2000-01-17 Neurogen Corporation 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands
US6291463B1 (en) 1998-06-30 2001-09-18 Neurogen Corporation 1-(Benzothiazol-2-yl)-4-(1-phenylmethyl) piperazines: dopamine receptor subtype specific ligands
DE19844291A1 (de) * 1998-09-18 2000-03-23 Schering Ag Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln
GB9912411D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
CA2426706A1 (en) * 2000-10-26 2002-05-02 Smithkline Beecham P.L.C. Benzoxazinone derivatives, their preparation and use
GB0203804D0 (en) 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0209244D0 (en) * 2002-04-23 2002-06-05 Glaxo Group Ltd Compounds
GB0227240D0 (en) * 2002-11-21 2002-12-31 Glaxo Group Ltd Compounds
ES2232292B1 (es) * 2003-07-30 2006-11-01 Laboratorios Del Dr. Esteve, S.A. Compuestos sulfonamidicos derivados de benzoxazinona, su preparacion y uso como medicamentos.
CN100455573C (zh) * 2005-11-11 2009-01-28 华东理工大学 一种制备1,4-苯并噁唑嗪-3-酮化合物的微波合成方法
KR200482995Y1 (ko) 2015-08-19 2017-03-23 이현진 물 공급부를 구비하는 얼음 트레이
MX2023012054A (es) * 2021-04-23 2023-10-23 Shanghai Hansoh Biomedical Co Ltd Inhibidor derivado heterociclico y metodo de preparacion y su aplicacion.
WO2023178035A1 (en) 2022-03-14 2023-09-21 Slap Pharmaceuticals Llc Multicyclic compounds
EP4514795A4 (en) * 2022-04-28 2025-12-31 Ningbo Newbay Tech Development Co Ltd COMPOUNDS USED AS PARP1 INHIBITORS
CN117903159A (zh) * 2022-12-30 2024-04-19 成都硕德药业有限公司 一种内酰胺类衍生物、其制备方法及用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613598A (en) * 1984-03-13 1986-09-23 Mitsubishi Chemical Industries Limited Piperazine derivatives and their acid addition salts
EP0233728A1 (en) * 1986-02-11 1987-08-26 Takeda Chemical Industries, Ltd. 1,4-Benzoxazine derivatives their production and use
US5523299A (en) * 1992-08-06 1996-06-04 Smithkline Beecham Plc 5-(2-oxyphenyl)-pyrrole derivatives as dopamine D3 receptor antagonists

Also Published As

Publication number Publication date
CN1074764C (zh) 2001-11-14
NO312296B1 (no) 2002-04-22
DE69718786T2 (de) 2003-10-23
IL126895A0 (en) 1999-09-22
GEP20012389B (en) 2001-03-25
KR20000016151A (ko) 2000-03-25
ID17266A (id) 1997-12-18
HRP970301B1 (en) 2002-08-31
AR008372A1 (es) 2000-01-19
EA001486B1 (ru) 2001-04-23
BG102959A (en) 1999-08-31
PT906294E (pt) 2003-06-30
NZ332737A (en) 2000-06-23
EE03686B1 (et) 2002-04-15
PE69398A1 (es) 1998-12-02
EP0906294B1 (en) 2003-01-29
AU3072797A (en) 1998-01-05
CO4940505A1 (es) 2000-07-24
PL330195A1 (en) 1999-04-26
AU731104B2 (en) 2001-03-22
JP2000511534A (ja) 2000-09-05
EP0906294A1 (en) 1999-04-07
DK0906294T3 (da) 2003-05-05
HN1997000075A (es) 1997-07-30
IL126895A (en) 2001-06-14
SK282703B6 (sk) 2002-11-06
NO985531L (no) 1998-11-27
CZ384698A3 (cs) 1999-03-17
DE69718786D1 (de) 2003-03-06
BR9709630A (pt) 1999-08-10
CA2253406A1 (en) 1997-12-04
SK162798A3 (en) 1999-06-11
EE9800417A (et) 1999-06-15
SI0906294T1 (en) 2003-04-30
HUP9903758A3 (en) 2000-07-28
CN1219930A (zh) 1999-06-16
RO120845B1 (ro) 2006-08-30
TW542833B (en) 2003-07-21
UY24569A1 (es) 2001-08-27
PA8431101A1 (es) 2001-12-14
HRP970301A2 (en) 1998-04-30
EA199800987A1 (ru) 1999-06-24
HUP9903758A2 (hu) 2000-06-28
ATE231846T1 (de) 2003-02-15
ES2191180T3 (es) 2003-09-01
HK1019737A1 (en) 2000-02-25
WO1997045419A1 (en) 1997-12-04
BG64049B1 (bg) 2003-11-28
NO985531D0 (no) 1998-11-27

Similar Documents

Publication Publication Date Title
SV1997000047A (es) Antagonistas de receptor de benzoxazinona dopamina d4
ES2196534T3 (es) Antagonistas del receptor de vitronectina.
ECSP014130A (es) Compuestos heterociclicos como ligandos de los receptores gaba.
ES2174836T3 (es) Heterrociclos nitrogenados triciclicos condesados como antagonistas de receptor de la sustancia p.
CR8267A (es) Compuestos de bencimidazolona que tiene actividad agonista del receptor 5-ht4
HN1999000149A (es) Derivados de 4,4-biarilpiperidina
PA8456601A1 (es) 4-aminopirrol (3,2-d) pirimidinas como antagonistas del receptor del neuropeptido y
PT1305286E (pt) Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento
PA8442601A1 (es) Peptidos y compuestos que se enlazan a un receptor
CR6478A (es) Moduladores del receptor glucocorticoide
ES2172701T3 (es) Mezclas insecticidas sinergicas.
ES2123482T3 (es) Receptor de estrogeno.
ES2172535T3 (es) Antagonistas de los receptores de la endotelina.
ES2148329T3 (es) Antagonistas del receptor de fibrinogeno.
SV2003000756A (es) Agonistas del adrenoreceptor beta-3 derivado de croma aminometilo doblemente substituido ref. 5061-sv
SV2004001250A (es) Agonistas muscarinicos ref, x - 15335
MX9300602A (es) Analogos de fenilalanina de bombesina.
ES2156889T3 (es) Compuestos biciclicos antagonistas de receptores de aminoacidos excitativos.
CO4410322A1 (es) Nuevos compuestos de carboxamida, sus sales farmaceuticamente aceptables y composiciones farmaceuticas que los contienen
SV2003000849A (es) Antagonistas de receptores de histamina ref.pcs10963aksr/bb
ECSP972135A (es) Antagonistas de receptor de benzoxazinona dopamina d4
MX9307047A (es) Compuestos de quinazolinas y bencimidazoles substituidos.
BR9801049A (pt) Processo para a preparação de um composto de -clorocetona e, - didiclorocetona e uso de ácido tricloro cianúrico.
ES2137999T3 (es) Procedimiento para sintetizar intermedios utiles de compuestos de imidazol sustituidos.
MX9302312A (es) Compuestos agonistas y antagonistas receptores de la progesterona, no esteroides y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG Grant
FD Lapse